NPPA Decision: Drug prices regulator NPPA said on Monday that it has fixed the retail price of 74 drugs, including drugs for the treatment of diabetes and high blood pressure. The National Pharmaceutical Pricing Authority (NPPA) has fixed the prices of drugs under the Drugs (Prices Control) Order 2013 based on the decision taken in the 109th meeting of the Authority held on 21st February.
NPPA issued notification
According to the notification, NPPA has dapagliflozin sitagliptin And metformin hydrochloride (extended-release tablets) The price of one tablet has been fixed at Rs 27.75.
Know the cost of blood pressure lowering medicine
Similarly, the regulator that fixes the price of drugs has prescribed telmisartan And bisoprolol fumarate The price of one tablet has been fixed at Rs 10.92. The NPPA has also revised the ceiling prices of 80 notified drugs (NLEM 2022), including those used in the treatment of epilepsy and neutropenia.
NPPA decides on the cost of drugs and drug formulations
The NPPA enforces and amends the provisions of the Drugs (Prices Control) Order. Apart from fixing the prices of controlled bulk drugs and formulations, NPPA is also responsible for ensuring the availability of drugs.
Changes in the prices of these medicines
sodium valproate The price of the drug containing one tablet (200 mg) has been revised by NPPA and fixed at Rs.3.20 per tablet. Other than this Filgrastim injection The price of (one vial) has been fixed at Rs.1034.51. Other than this hydrocortisone Which is a steroid, its price has been changed to Rs 13.28 per tablet.